Thursday, December 4, 2025

Verano: Analysts Expect Q3 Revenues Of $219.7 Million

Verano Holdings (CSE: VRNO) announced that they will be reporting their third quarter financials before the market opens on November 16th.

Analysts have a consensus C$40.38 12-month price target on the company, via a total of 7 analysts, with 2 analysts having strong buy ratings, and the other 5 having buy ratings on the company. The street high comes from Beacon Securities with a C$47 price target, and the lowest target sits at C$35.

7 analysts have revenue estimates for the third quarter. The mean between all 7 is US$219.70 million; this number has been revised slightly down from US$224.82 million at the start of May. The street high is US$224.60 million while the lowest sits at US$210 million.

7 analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 55.41%, with this number revised down from 60.72% at the start of May. Street high is a 58% estimate and the lowest sits at 53%.

Onto EBITDA estimates, there are currently 7 analysts who have third-quarter EBITDA estimates. The mean is currently US$85.64 million, with this number being revised down from US$100.17 million since the start of May. Street high sits at US$93.50 million EBITDA and the lowest being a US$63.70 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Copper Is Heading To $30 And Silver To $200 | Craig Parry

Mako Mining Q3 Earnings: The Transitional Quarter

B2Gold Q3 Earnings: Goose Troubles Cloud The Narrative

Recommended

Emerita Resources Awards Contract For Pre-Feasibility Study On Iberian Belt West Project

Selkirk Copper Appoints Two Members Of Selkirk First Nation To Leadership Team

Related News

Antibe: Canaccord Lowers Price Target After Co-Leading $40.4 Million Financing

Wednesday, Antibe Therapeutics (TSX: ATE) announced that they closed their bought deal financing. The bought...

Friday, February 26, 2021, 11:55:00 AM

Trulieve Cannabis: Second Quarter 2021 Analyst Consensus Estimates

Trulieve Cannabis (CSE: TRUL) announced that they will be reporting their second quarter financials before...

Monday, August 9, 2021, 11:32:00 AM

Organigram: Consensus Price Target Falls To $3.55

On November 23rd, Organigram Holdings (TSX: OGI) announced its fourth quarter fiscal 2021 results. The...

Sunday, November 28, 2021, 01:18:00 PM

Apple: “Records Are Made To Be Broken,” Earnings Results Smash Expectations

Apple opened 2.6% higher after its fiscal second-quarter results were released earlier in the week,...

Sunday, May 2, 2021, 03:51:00 PM

Paypal: Analysts Forecast Q2 Revenues Of $6.26 Billion

Paypal (NASDAQ: PYPL) will be reporting its second quarter financial results today after market close....

Wednesday, July 28, 2021, 03:03:00 PM